Covered recipient · General Payments record
LAURIE A KANE
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$6,541.77
- Reported across 340 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $268.11 | 10 |
| Education | $64.54 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $193.41 | 6 |
| ABBVIE INC. | $33.50 | 1 |
| Lilly USA, LLC | $31.79 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.70 | 1 |
| IBSA Pharma Inc. | $22.25 | 1 |
| Amgen Inc. | $14.77 | 1 |
| Nevro Corp. | $14.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.50 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104026621 | CMS |
| Amgen Inc. | $14.77 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111613683 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.70 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118131143 | CMS |
| IBSA Pharma Inc. | $22.25 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142983887 | CMS |
| Lilly USA, LLC | $31.79 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135121085 | CMS |
| Nevro Corp. | $14.23 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130753157 | CMS |
| Novo Nordisk Inc | $8.67 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097118055 | CMS |
| Novo Nordisk Inc | $3.17 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097341000 | CMS |
| Novo Nordisk Inc | $2.98 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097116085 | CMS |
| Novo Nordisk Inc | $114.05 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097294585 | CMS |
| Novo Nordisk Inc | $32.27 | 10/03/2024 | Education | Undisputed | 01/23/2026 | 1097075848 | CMS |
| Novo Nordisk Inc | $32.27 | 10/03/2024 | Education | Undisputed | 01/23/2026 | 1097425078 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.